US Patent 9580391 Saturated acyl guanidine for inhibition of F
Patent 9580391 was granted and assigned to Lycera on February, 2017 by the United States Patent and Trademark Office.
All edits
Edits on 6 Dec, 2023
Golden AI
Edits made to:
Article (+267 characters)
Article
Patent abstract
The invention provides saturated acyl guanidine compounds that inhibit F1F0-ATPase, and methods of using saturated acyl guanidine compounds as therapeutic agents to treat medical disorders, such as an immune disorder, inflammatory condition, or cancer.
Edits on 30 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Alexander R. Hurd0
Chad A. Van Huis0
Clarke B. Taylor0
Peter L. Toogood0
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09580391 Saturated acyl guanidine for inhibition of F US Patent 9580391 Saturated acyl guanidine for inhibition of F
Infobox
Patent Number
095803910
Patent Number
95803910
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
095803910
Date of Patent
February 28, 2017
0Patent Application Number
144037910
Date Filed
June 7, 2013
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 10 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09580391 Saturated acyl guanidine for inhibition of F
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09580391
Date of patent
February 28, 2017
Patent application number
14403791
Date Filed
June 7, 2013
Patent primary examiner
Find more entities like US Patent 9580391 Saturated acyl guanidine for inhibition of F
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.